The story of Sildenafil offers a complicated case study for analysts eyeing drug companies. While initial sales were remarkable, recent patent expiry and the arrival of cheaper versions have significantly influenced https://inesuzvf005604.blogofchange.com/41682938/sildenafil-and-big-pharma-a-precarious-investment